Yu-li Wang, PhD, appointed to 4-year term on National Advisory General Medical Sciences Council

May 8, 2003

WORCESTER, Mass. – Yu-li Wang, PhD, a professor in physiology and cell biology at the University of Massachusetts Medical School, has been appointed to a four-year term on the National Advisory General Medical Sciences Council, a committee made up of leaders in the biological and medical sciences, education, health care and public affairs from across the nation. The Council ensures the quality of research funded through grants awarded by the National Institute of General Medical Sciences and offers advice on its policy. The NIGMS is part of the National Institutes of Health.

“It’s a great honor to be on the Council,” said Dr. Wang, noting that the Council enjoys a broad view of research underway nationwide and exerts significant influence on the NIH by serving an advisory function to shape the direction of future research funding. The NIH awards some $19 billion in grants annually; UMMS received approximately $93 million last year.

The mission of the NIGMS includes the support of basic research and research training of the highest quality in the areas of biophysics and physiological sciences, cellular and molecular biology, genetics, and the pharmacological and biorelated chemical sciences. Members of the Council meet three times a year to perform the second level of peer review of grant applications, which are first examined through a rigorous study section process. The Council also offers recommendations on program development, implementation and evaluation.

Dr. Wang’s work at UMMS is supported by a MERIT award from NIH and by NASA and focuses on the mechanism of cell locomotion and guidance, the mechanism of cellular responses to mechanical stimulation, the regulation of cellular structural assembly and disassembly, and the mechanism of cell division. His laboratory uses cell manipulation and digital imaging, combined with biochemical, biophysical and molecular biological techniques, to study dynamic events in living cells.

The University of Massachusetts Medical School, one of the fastest growing medical schools in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $143 million in research funding annually, 80 percent of which comes from federal funding sources. Research funding enables UMass scientists to explore human disease from the molecular level to large-scale clinical trials. Basic and clinical research leads to new approaches for diagnosis, treatment and prevention of disease.


Contact: Alison Duffy, 508-856-2000